CRUK RadNet City of London Seminar Series #2
26th January 2021 at 16:00 – 17:00
Hosted by Dr Crispin Hiley, Radiation Oncology Consultant at UCLH and Associate Professor at the UCL Cancer Institute, our international guest speaker Dr Clifton David Fuller, MD Anderson Cancer Center will be giving a talk on‘ Imaging applications for head and neck radiotherapy toxicity monitoring & reduction‘.
Dr Clifton David Fuller -Associate Professor; Medical Director, Program for Image-Guided Cancer Therapy, MD Anderson Cancer Center
I am a mid-career Established Investigator physician-scientist with research focused on development of quantitative spatial/non-spatial informatics models of both oncologic outcomes and iatrogenic sequelae after head and neck cancer, integrated into patient care through clinical trials. My work has focused specifically on tumor and normal tissue injury response using imaging data, leveraging “Big Data” statistical approaches to improve not only cancer control, but also orodental toxicity reduction in the multi-institutional setting.
After NIH NIA T25 pre-doctoral, NCI R25- and NCRR M01-funded medical student research experiences, I gained expertise in human imaging physics in a T32-supported joint PhD-residency program, before a K12 Paul Calabresi Fellowship in clinical trials and imaging informatics. I am an ABPM subspecialty-boarded in Clinical Informatics to supplement ABR board certification in Radiation Oncology. As an oncologist and informatician with formal imaging science training, I am uniquely positioned to serve on the proposed application. This expertise led to a P50-funded SPORE Career Development Award and subsequent research independence as Primary Investigator on four R01 awards (R01CA225190, R01CA214825, R01CA218148, R01DE028290) and two NSF awards (DMS-1557679, CMMI-1933369).
As PI of an NIBIB R25 fellowship program, I am recognized as a leading educator in cancer imaging and informatics. Notably, I have served as a mentor for >100 trainees internationally and domestically, including 4 pre-doctoral trainees with NIDCR/NCI Diversity Supplements, NCATS TL1 pre- and post-doctoral awardees, an NIDCR F31 NRSA Predoctoral Fellow, 2 NIBIB R25 Fellows, and a NCI K12 Fellow.
Please see video below: